
Mitochondrial DNA variant predicts resistance to melanoma immunotherapy
Results from a new study help resolve the decade-long mystery of why many patients with the deadliest form of skin cancer do not respond to the latest cancer treatments. Specifically, researchers found patients with metastatic melanoma who did not respond …